Journal of Applied Physiology AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 94: 631-641, 2003. First published October 11, 2002; doi:10.1152/japplphysiol.00642.2002
8750-7587/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
94/2/631    most recent
00642.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (59)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, J. N.
Right arrow Articles by Wojtaszewski, J. F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, J. N.
Right arrow Articles by Wojtaszewski, J. F. P.
Vol. 94, Issue 2, 631-641, February 2003

5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle

Jakob N. Nielsen1, Kirsty J. W. Mustard2, Drew A. Graham1, Haiyan Yu3, Christopher S. MacDonald1, Henriette Pilegaard4, Laurie J. Goodyear3, D. Grahame Hardie2, Erik A. Richter1, and Jørgen F. P. Wojtaszewski1

1 Institute of Exercise and Sport Sciences and 4 August Krogh Institute, Copenhagen Muscle Research Centre, University of Copenhagen, DK-2100 Copenhagen, Denmark; 2 Wellcome Trust Biocentre, Division of Molecular Physiology, University of Dundee, Dundee DD1 4HN, Scotland, United Kingdom; and 3 Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

5'-AMP-activated protein kinase (AMPK) has been proposed to be a pivotal factor in cellular responses to both acute exercise and exercise training. To investigate whether protein levels and gene expression of catalytic (alpha 1, alpha 2) and regulatory (beta 1, beta 2, gamma 1, gamma 2, gamma 3) AMPK subunits and exercise-induced AMPK activity are influenced by exercise training status, muscle biopsies were obtained from seven endurance exercise-trained and seven sedentary young healthy men. The alpha 1- and alpha 2-AMPK mRNA contents in trained subjects were both 117 ± 2% of that in sedentary subjects (not significant), whereas mRNA for gamma 3 was 61 ± 1% of that in sedentary subjects (not significant). The level of alpha 1-AMPK protein in trained subjects was 185 ± 34% of that in sedentary subjects (P < 0.05), whereas the levels of the remaining subunits (alpha 2, beta 1, beta 2, gamma 1, gamma 2, gamma 3) were similar in trained and sedentary subjects. At the end of 20 min of cycle exercise at 80% of peak O2 uptake, the increase in phosphorylation of alpha -AMPK (Thr172) was blunted in the trained group (138 ± 38% above rest) compared with the sedentary group (353 ± 63% above rest) (P < 0.05). Acetyl CoA-carboxylase beta -phosphorylation (Ser221), which is a marker for in vivo AMPK activity, was increased by exercise in both groups but to a lower level in trained subjects (32 ± 5 arbitrary units) than in sedentary controls (45 ± 1 arbitrary units) (P < 0.01). In conclusion, trained human skeletal muscle has increased alpha 1-AMPK protein levels and blunted AMPK activation during exercise.

acetyl coenzyme A-carboxylase-beta ; phosphocreatine; adenine nucleotides; glycogen


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

5'-AMP-ACTIVATED PROTEIN KINASE (AMPK) is a ubiquitously expressed sensor of cellular energy charge. On activation, AMPK switches off ATP-consuming anabolic processes and turns on ATP-producing catabolic processes via phosphorylation of several downstream metabolic enzymes and via effects on gene expression (recently reviewed by Ref. 21). AMPK is activated by acute exercise in human skeletal muscle (6, 19, 35, 44, 49, 57), and several studies propose a regulatory role for AMPK in exercise-induced fatty acid oxidation (reviewed by Refs. 53, 54) and glucose metabolism (reviewed by Refs. 20, 43).

Repeated bouts of acute exercise over a prolonged period of time (exercise training) induce health-beneficial adaptations in several body tissues (4). Many of the adaptations taking place in skeletal muscle in response to exercise training are proposed to involve AMPK. This is based on the observations that chronic pharmacological activation of AMPK, like exercise training, both enhances the gene expression of the glucose transporter GLUT-4, hexokinase, citrate synthase, and cytochrome c and increases mitochondrial density and muscle glycogen content in rodent skeletal muscle (3, 5, 25, 55, 61). Furthermore, chronic activation of AMPK by 5-aminoimidazole-4-carboxamide-1-beta -D-ribofuranoside (AICAR) increases insulin-induced glucose utilization in rodent skeletal muscle (5, 15) similar to exercise training (10, 11, 38). However, AICAR may be somewhat nonspecific in activating AMPK (2), and, therefore, these findings should be interpreted carefully. Supporting the direct role of AMPK in these adaptations is a study in which a constitutively active AMPK mutant is expressed in the H-2Kb skeletal muscle cell line. These experiments show that increased AMPK activity is sufficient to increase GLUT-4 and hexokinase protein levels (18) and suggest a key role for AMPK activity in the metabolic adaptations to exercise training.

AMPK is a heterotrimer consisting of three subunits designated as alpha , beta , and gamma . In mammalian cells, two isoforms of the alpha -subunit, which contains the catalytic domain, have been identified (alpha 1 and alpha 2). The beta  (beta 1 and beta 2 isoforms) and the gamma  (gamma 1, gamma 2, and gamma 3 isoforms) regulatory subunits are needed in complex with the alpha -subunit for full kinase activity (14, 59). The alpha 1-isoform is widely distributed in different body tissues, whereas alpha 2 is primarily expressed in skeletal muscle, heart, and liver (47). In INS-1 cells and skeletal muscle tissue, alpha 1 is mainly found in the cytosol, whereas alpha 2 is localized both in cytosol and nuclei (1, 45). Interestingly, of the two beta -subunits identified, the beta 2-protein is abundantly expressed in skeletal muscle compared with beta 1 (50). AMPK gamma 1- and gamma 2-mRNA are found in a variety of tissues, whereas significant expression of gamma 3-mRNA was detected in skeletal muscle only, although the protein appeared to be much more widely expressed (7).

Regulation of AMPK activity involves several mechanisms. Allosteric activation of AMPK is brought about by an increase in the AMP-to-ATP ratio (AMP/ATP) and a decrease in the phosphocreatine-to-creatine ratio (PCr/Cr) (41). Furthermore, AMPK is covalently activated by kinases (AMPKKs) via phosphorylation on Thr172 of the alpha -subunit (23, 48). AMPKK, like AMPK, is also allosterically activated by AMP (24, 48) but appears not to be regulated by PCr. Binding of AMP to AMPK makes the enzyme a better substrate for AMPKK (23) and a worse substrate for deactivating protein phosphatases (9). Altogether, these mechanisms would ensure that the AMPK system responds to changes in cellular AMP in an ultrasensitive manner (22). Recent studies suggest a role for glycogen in the regulation of AMPK activity. In rodent skeletal muscle, high muscle glycogen levels, induced by exercise training or a combination of prior exercise and diet, are associated with low-basal and exercise- or AICAR-stimulated alpha 2-AMPK activity, compared with skeletal muscle with normal or low-glycogen levels (12, 28, 56). Importantly, this effect of glycogen is possibly independent of changes in adenine nucleotide concentrations (56).

Taken together, there is evidence to suggest that AMPK may mediate many of the effects of acute exercise and exercise training on skeletal muscle substrate metabolism and gene expression. Recently, a study investigated AMPK activity and AMPK subunit protein levels in trained and untrained rat skeletal muscle after exercise at the same absolute workload and observed a blunted exercise-induced AMPK activity and an increased protein level of the gamma 3-subunit in the red quadriceps muscle of the trained animals (13). In human skeletal muscle, the regulation of AMPK has been studied by using different exercise intensities (57), but the effect of training status on exercise-induced AMPK activity has so far not been elucidated in humans. Given the possible role of AMPK in exercise-induced gene expression, we hypothesized that exercise training regulates the gene expression and protein levels of AMPK in human skeletal muscle. In the present study, regulation of AMPK in human skeletal muscle from exercise-trained and sedentary subjects was studied at rest and during exercise at the same relative workload. Furthermore, gene expression and protein levels of the various AMPK subunit isoforms were determined.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subjects. Fourteen young healthy men (7 exercise-trained and 7 sedentary subjects) gave their informed consent to participate in the study. The exercise-trained subjects participated in physical exercise training (long-distance running, bicycle road racing, and indoor cycle spinning) four to eight times per week, whereas the sedentary control subjects did not participate in any regular physical activity. One to two weeks before the experiment, peak O2 consumption (VO2 peak) was determined during an incremental cycle ergometer test. The VO2 peak was >59 and <46 ml O2 · min-1 · kg-1 for the trained and sedentary subjects, respectively.

Experimental protocol. The day before the experiment, the subjects abstained from exercise and ate a mixed diet (57% carbohydrates, 27% fat, 16% protein). On the day of the experiment, the subjects arrived in the laboratory in the morning after a 10-h overnight fast. A catheter was inserted in the antecubital vein of the forearm for blood sampling. The subjects exercised for 20 min on a cycle ergometer (Monark) at the same relative workload (80% of VO2 peak). Pulmonary oxygen and carbon dioxide exchange was measured by using an on-line gas and airflow analyzer (Medgraphics, Medical Graphics). Glucose and fat oxidation were evaluated by indirect calorimetry according to Frayn (17), with the exception that measurements were not corrected for urinary nitrogen. Needle biopsies from vastus lateralis muscle and blood samples were obtained at rest and at the end of exercise under local anesthesia by using Xylocain (Lidocain). The Copenhagen Ethics Committee approved the experimental protocol, and all human experiments conformed to the Declaration of Helsinki.

Analysis of blood and plasma substrates and hormones. Glucose and lactate concentrations in blood were determined in duplicate by using a dual-channel glucose-lactate analyzer (YSI-2700 Select; Yellow Springs Instruments, Yellow Springs, OH). Plasma insulin concentration was determined by using a radioimmunoassay kit (Insulin Ria 100, Pharmacia). Concentrations of plasma long-chain fatty acids (LCFA) were determined in accordance with Shimizu et al. (46) by using an automatic spectrophotometer (COBAS FARA 2, Roche Diagnostic). Plasma epinephrine and norepinephrine were analyzed by means of a radioimmunoassay (KatCombi, Immuno-Biological Laboratories, Hamburg, Germany).

Muscle lactate, adenosine nucleotides, Cr, and PCr. Freeze-dried muscle biopsy specimens were extracted with perchloric acid, neutralized, and analyzed for lactate and adenosine nucleotides. Contents of ATP, ADP, AMP, and IMP were determined by reverse-phase HPLC, according to a previously described method (52). Muscle lactate, Cr, and PCr content were measured fluorometrically, as described previously (37). The estimation of free concentrations of ADP and AMP was based on the near-equilibrium nature of the Cr phosphokinase and adenylate kinase reactions, respectively. Free ADP was estimated from the measured ATP, Cr, and PCr contents, and the H+ concentration was estimated by using the measured muscle lactate content, according to the formula for dry muscle presented by Mannion et al. (33). The equilibrium constant value employed for Cr phosphokinase was 1.66 × 109 M-1 (29). Free AMP (AMPfree) was estimated from the measured ATP and the estimated free ADP by using an observed equilibrium constant for adenylate kinase of 1.05 (29).

Muscle glycogen. Muscle glycogen concentration in freeze-dried muscle tissue was measured by fluorometry as glycosyl units after acid hydrolysis, as previously described (37).

Muscle lysate preparation. For studies of enzyme activity and phosphorylation, ~40 mg of frozen muscle tissue were homogenized, as described previously (34). Homogenates were rotated end over end at 4°C for 60 min, after which they were centrifuged at 4°C for 30 min at 4,000 g. The supernatants were harvested, and total protein content was determined in the lysates by the bicinchoninic acid method (Pierce). For measurement of protein levels of the AMPK subunit isoforms, muscle lysates were prepared, as described previously (13).

AMPK activity. alpha -Isoform-specific AMPK activity was measured in immunoprecipitates from 100 µg of muscle lysate protein by using an anti-alpha 1-AMPK and an anti-alpha 2-AMPK antibody. A p81 filter paper assay, with the use of SAMS-peptide (200 µM) as the substrate, was used to measure AMPK activity in the presence of a saturating concentration of AMP (0.2 mM), as previously described (57).

AMPK and acetyl CoA-carboxylase-beta phosphorylation. The phosphorylation of the alpha -subunits (Thr172) and acetyl CoA-carboxylase (ACC)-beta (Ser221) was evaluated by Western blotting by using phospho-specific antibodies from Cell Signaling Technology and Upstate Biotechnology, respectively. The ACC phospho-specific antibody is raised against a peptide corresponding to the sequence in rat ACC-alpha containing the Ser79 phosphorylation site, but the antibody also recognized the human ACC-beta when phosphorylated, most likely at the corresponding Ser221. For the detection of alpha -AMPK phosphorylation (Thr172), 45 µg of muscle lysate protein were subjected to SDS-PAGE (4-15% gradient gel) and Western blotting. ACC-beta was affinity purified from 300-µg muscle lysate protein and subjected to SDS-PAGE (4-15% gradient gel), as described previously (6). Immunoreactive bands were visualized with enhanced chemiluminescense (ECL+, Amersham Pharmacia Biotech) and detected and quantified with the use of a coupled device image sensor and 1D software (Image Station, E440CF, Kodak).

AMPK subunit mRNA. For the determination of mRNA content, isolation of total RNA, RT, and PCR were carried out as follows. Total RNA was isolated from ~25 mg of tissue by a modified guanidinium thiocyanate-phenol-chloroform extraction method adapted from Chomczynski and Sacchi (8) and as described previously (40). RNA was resuspended overnight (4°C) in 2 µl/mg original tissue weight in diethyl pyrocarbonate-treated H2O containing 0.1 mM EDTA. RT of 22 µl of total RNA sample was performed by using the Superscript II RNase H- system (GIBCO-BRL), as previously described (40). RT products were diluted in nuclease-free H2O to a total volume of 300 µl. The mRNA content of the selected genes was determined by fluorescence-based real-time PCR (ABI PRISM 7700 Sequence Detection System, Applied Biosystems). Forward (FP) and reverse primers (RP) and TaqMan probes were designed from human-specific sequence data (Entrez-NIH and Ensemble, Sanger Institute) by using computer software (Primer Express, Applied Biosystems). The following sequences were used to amplify a fragment of AMPK-alpha 1 FP: 5' CAGGGACTGCTACTCCACAGAGA 3'; RP: 5' CCTTGAGCCTCAGCATCTGAA 3'; probe: 5' TCAGTTAGCAACTATCGATCTTGCCAAAGGAGT 3'; and of AMPK-alpha 2 FP: 5' CAACTGCAGAGAGCCATTCACTT 3'; RP: 5' GGTGAAACTGAAGACAATGTGCTT 3'; probe: 5' CTGGCTCTCTCACTGGCTCTTTGACCG 3'; and of AMPK-gamma 3 FP: 5' GGAAGTGATCGACAGGATTGC 3'; RP: 5' GAGATGCTGGGTCTCGTCCA 3'; probe: 5' CGGGAGCAGGTACACAGGCTGGTG 3'. The probes were 5'6-caboxyfluorescein (FAM) and 3'6-carboxy-N,N,N',N'-tetramethylrhodamine (TAMRA) labeled. Prior optimization was conducted for each set of self-designed oligos determining optimal primer concentrations and probe concentration and verifying the efficiency of the amplification. For each of the target genes, the expected size of the PCR product was confirmed on a DNA 2.5% agarose gel. GAPDH was also amplified for use as endogenous control by using a predeveloped assay reaction (Applied Biosystems). PCR amplification was performed (in triplicates) in a total reaction volume of 25 µl. The reaction mixture consisted of 2.5 µl diluted template, FP and RP, and probe, as determined from the prior optimization, 2× TaqMan Universal MasterMix optimized for TaqMan reactions (Applied Biosystems; containing AmpliTaq Gold DNA polymerase, AmpErase Uracil N-glycosylase, dNTPs with dUTP, ROX as passive reference, and buffer components), and nuclease-free water. The following cycle profile was used for all genes: 50°C for 2 min + 95°C for 10 min + [95°C for 15 s + 60°C for 1 min] × 40 cycles.

AMPK subunit protein levels. Western blotting for the AMPK subunit isoforms was performed as described previously (13), except in the case of gamma 1. In the latter case, a "pan" gamma -antibody was generated in sheep to the peptide CRAAPLWDSKKQSFVG (residues 69-83 plus NH2-terminal cysteine) of rat gamma 1, a sequence highly conserved in human gamma 2 and gamma 3) coupled to keyhole limpet haemocyanin and affinity purified as described previously (59).

Statistics. Data are expressed as means ± SE. Two-tailed nonpaired Student's t-tests were applied for comparison of two normally distributed groups. Comparisons between two normally distributed groups before and at the end of exercise were done by two-way ANOVA for repeated measures for the detection of main effects and interactions between the different groups. If interactions between groups were detected, two-way ANOVA for repeated measures was followed by a multiple-comparison test (Student-Newman-Keuls method). Correlations were analyzed by Pearson product-moment correlation analysis for two parameters and with multiple linear regression for three parameters. P < 0.05 was considered statistically significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subject characteristics. Age (25 ± 1 vs. 25 ± 1 yr), height (183 ± 3 vs. 186 ± 2 cm), body weight (79 ± 4 vs. 86 ± 3 kg), and body mass index (24 ± 1 vs. 25 ± 1 kg/m2) were similar in the exercise-trained and the sedentary subjects, respectively, whereas VO2 peak was significantly higher in the trained than in the sedentary subjects (66 ± 2 vs. 44 ± 1 ml O2 · min-1 · kg-1; P < 0.05).

Pulmonary and cardiac responses to exercise. The trained and sedentary subjects exercised at the same relative workload, eliciting a similar heart rate, respiratory exchange ratio, and fat oxidation rate determined during the last 2 min of exercise. The workload, pulmonary oxygen uptake, and carbohydrate oxidation rate were significantly higher in the trained than in the sedentary subjects (P < 0.05) (Table 1).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Pulmonary and cardiac responses to acute exercise

Blood and plasma substrates and hormones. In the resting condition, blood glucose, blood lactate, plasma LCFA, plasma insulin, plasma epinephrine, and plasma norepinephrine were similar in trained and sedentary subjects. In response to exercise, blood lactate and plasma epinephrine increased (P < 0.001) and plasma LCFA and plasma insulin decreased (P < 0.001), but no differences were present between the two groups. Blood glucose increased in response to exercise in the trained subjects (P < 0.01) to a higher level than in the sedentary subjects (P < 0.05). Plasma norepinephrine increased in response to exercise in both groups, but, at the end of exercise, the concentration was significantly higher in the trained group (Table 2).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Blood substrates and hormones at rest and at the end of 20-min exercise

Muscle lactate, nucleotides, Cr, and PCr. Muscle lactate was not different between sedentary and trained subjects at rest, and in both groups muscle lactate increased in response to exercise. However, at the end of exercise, muscle lactate was significantly lower in the trained than in the sedentary group (Table 3). No differences in ATP, AMP, IMP, Cr, or PCr concentrations or AMP/ATP or PCr/(PCr + Cr) were present between the trained and sedentary group in the resting state, whereas the ADP concentration was lower in the trained group (P < 0.01, main effect). The ADP, IMP, and Cr concentrations increased, whereas the PCr concentration and PCr/(PCr + Cr) decreased in response to exercise (P < 0.01). At the end of the exercise bout, the Cr content was lower and the PCr content and PCr/(PCr + Cr) were higher (P < 0.05) in the trained subjects than in the sedentary subjects (Table 3). The calculated concentration of cytosolic AMP (AMPfree) and AMPfree/ATP increased in response to acute exercise, and, although there appeared to be a larger increase in the sedentary group, this was not significant (Table 3). It should be noted that calculation of AMPfree involves estimation of the muscle H+ concentration from the measured muscle lactate concentration. As trained muscle has a higher dynamic buffer capacity for H+, a given measured lactate accumulation will be followed by a smaller increase in H+ in trained than in sedentary muscle. This may lead to an underestimation of AMPfree in the trained group.

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Nucleotides, creatine, and phosphocreatine at rest and at the end of 20-min exercise

Muscle glycogen. In the resting state, the muscle glycogen content was higher in the trained than in the sedentary group (P < 0.05), and glycogen content decreased during exercise to a similar level in the two groups (P < 0.01) (Fig. 1). However, the decrease in glycogen content was not significantly different between the trained and sedentary subjects.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   Glycogen concentration in skeletal muscle of exercise-trained and sedentary subjects at rest and at the end of 20-min acute exercise. Values are means ± SE of n = 6-7 in each group. The mean values of the individual relative change are also given. * P < 0.05 vs. sedentary at rest. dagger  P < 0.01 vs. rest in corresponding group.

The alpha 1- and alpha 2-AMPK activities. The resting activities of alpha 1- and alpha 2-AMPK were not different between trained and sedentary subjects. The alpha 2-AMPK activity was significantly higher at the end of exercise (P < 0.01, main effect), although no significant difference was present between the trained and sedentary subjects (P = 0.24) (Fig. 2B). The increase in alpha 2-AMPK activity above resting level was 110 ± 33 and 184 ± 31% in trained and sedentary subjects, respectively, but these increases were not significantly different (P = 0.21).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   alpha 1- (A) and alpha 2- (B) associated 5'-AMP-activated protein kinase (AMPK) activity in skeletal muscle of exercise-trained and sedentary subjects at rest and at the end of 20-min exercise. Values are means ± SE of n = 7 in each group. The mean values of the individual relative change are also given. dagger  P < 0.01 vs. rest (main effect).

alpha -AMPK phosphorylation (Thr172). In concordance with alpha -AMPK activity, alpha -AMPK phosphorylation at Thr172 on the alpha -subunit was not different between the two groups of subjects at rest. In response to exercise, alpha -AMPK phosphorylation increased significantly (P < 0.01, main effect), and the increase in AMPK phosphorylation above the resting level was significantly reduced in the trained group compared with the sedentary group (Fig. 3).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   AMPK alpha -subunit phosphorylation (Thr172) in skeletal muscle of exercise-trained and sedentary subjects at rest and at the end of 20-min exercise. A representative Western blot is shown in the inset. Values are means ± SE of n = 7 in each group. The mean values of the individual relative change are also given. dagger  P < 0.01 vs. rest (main effect). * P < 0.05 vs. sedentary.

ACC-beta phosphorylation (Ser221). At rest, ACC-beta phosphorylation (Ser221) was not different between the trained and sedentary subjects. During exercise, ACC-beta phosphorylation was significantly increased in both groups (P < 0.001), but ACC-beta phosphorylation was significantly lower in the trained than in the sedentary subjects (P < 0.01), and the increase in ACC-beta phosphorylation above the resting level tended (P = 0.071) to be lower in the trained group than in the sedentary group (Fig. 4).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Acetyl CoA-carboxylase (ACC)-beta phosphorylation (Ser221) in skeletal muscle of exercise-trained and sedentary subjects at rest and at the end of 20-min exercise. A representative Western blot is shown in the inset. Values are means ± SE of n = 7 in each group. The mean values of the individual relative change are also given. dagger  P < 0.001 vs. rest in corresponding group. * P < 0.01 vs. sedentary during acute exercise.

AMPK subunit mRNA expression. The alpha 1-, alpha 2-, and gamma 3-subunits were chosen for mRNA expression analyses as the levels of these protein subunits have previously been shown to change in response to physiological perturbations in rodents (13, 51). The mRNA content of the alpha 1- and alpha 2-subunits of AMPK was not different between trained and sedentary subjects, but the level of gamma 3-mRNA tended to be lower (P = 0.078) in the trained group than in the sedentary group (Fig. 5).


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 5.   The mRNA content of AMPK subunit isoforms in skeletal muscle of exercise-trained subjects at rest expressed as percentage of the mRNA content in sedentary subjects. Values are means ± SE of n = 7.

AMPK subunit protein levels. The protein content of the AMPK alpha 1-subunit in trained muscle was 185% of that in sedentary muscle (P < 0.05) (Fig. 6). The beta 2-protein level in trained subjects was 148% of that in sedentary subjects (P = 0.06). Protein levels of alpha 2-, beta 1-, gamma 1-, gamma 2-, and gamma 3-subunits were similar in the trained and sedentary groups.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   Protein levels of AMPK subunit isoforms in skeletal muscle of exercise-trained and sedentary subjects at rest. A: representative Western blots. B: densitometric data expressed as percentage of sedentary. Values are means ± SE of n = 7. * P < 0.05 vs. sedentary.

Correlation analyses. When the data from the trained and the sedentary groups were pooled, the exercise-induced decrease in PCr/(PCr + Cr) correlated significantly with measures of exercise-induced changes in alpha -AMPK activity [alpha 1: r = 0.61, P = 0.02; alpha 2: r = 0.72, P = 0.005; alpha -AMPK phosphorylation (Thr172): r = 0.78, P = 0.002; and ACC-beta phosphorylation (Ser221): r = 0.67, P = 0.01] (not shown). The decrease in glycogen alone did not correlate with any of the obtained measures of increase in AMPK activity (not shown), probably due to the limited variability in the amount of glycogen broken down in the subjects. Nevertheless, the increase in alpha 2-AMPK activity was tightly correlated with the decrease in PCr/(PCr + Cr) and the decrease in glycogen when analyzed by multiple linear regression (r = 0.81, P = 0.005) (Fig. 7). No correlations were present between AMPfree/ATP (increase or absolute level) and any of the obtained measures of AMPK activity.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 7.   Relationship among the exercise-induced increase in alpha 2-AMPK activity, decrease in glycogen, and decrease in phosphocreatine (PCr)-to-[PCr + creatine (Cr)] ratio. A plane was fitted to the data by multiple linear regression (r = 0.81, P = 0.005, n = 13).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

In the present study, we investigated mRNA expression and protein levels of AMPK subunit isoforms and the effect of acute exercise on AMPK activity in skeletal muscle of trained and sedentary subjects. In response to acute exercise at 80% of VO2 peak, alpha 2-AMPK activity, alpha -AMPK phosphorylation (Thr172), and ACC-beta phosphorylation (Ser221) increased, whereas alpha 1-associated activity was unchanged. ACC-beta phosphorylation during exercise and the exercise-induced increase in alpha -AMPK phosphorylation were significantly blunted in the trained group compared with the sedentary group. No significant difference in skeletal muscle mRNA content for the alpha 1-, alpha 2-, and gamma 3-subunit could be detected between trained and sedentary subjects. At the protein level, the alpha 1-AMPK was significantly higher in trained subjects than in sedentary subjects.

In the context of a long-term training regime, it is well known that a continued progressive improvement of exercise performance and training-induced cellular adaptations, such as increased GLUT-4 levels, are dependent on a progressive increase in training amount and intensity (26, 39). The observation that exercise-induced AMPK activity is blunted in trained subjects compared with sedentary subjects working at the same relative intensity might in part explain this phenomenon, considering the possible role of AMPK in exercise-induced gene expression (see below). Despite higher absolute energy requirement in the trained than in the sedentary subjects at the same relative exercise intensity, the energy charge is better maintained in the trained individuals, as reflected by the difference in PCr/(PCr + Cr) between trained and sedentary subjects. Besides providing an explanation for the lower AMPK activation in the trained subjects, it illustrates the important point that AMPK activity is not a marker of total energy flux during exercise, but rather a result of the perturbations in the energy charge induced by exercise.

The blunted exercise-induced in vivo activity of AMPK in the trained group was reflected by a decreased Ser221 phosphorylation of its downstream target, ACC-beta . In accordance with our findings, studies in rats have demonstrated a blunted ACC inactivation by exercise at the same absolute workload after training in red quadriceps and gastrocnemius muscle (13, 27). Our finding that ACC-beta phosphorylation (Ser221) is reduced in trained subjects could be explained by an allosteric influence on AMPK of the low-Cr and high-PCr levels observed in the present study and by others (42). The improved maintenance of the PCr stores in the trained subjects during acute exercise is probably related to a higher capacity of oxidative ATP generation due to increased activity and expression of enzymes in the oxidative pathways. Furthermore, the diminished muscle lactate concentration during acute exercise in the trained subjects indicates a reduced exercise-induced acidification. This could also help explain the blunted AMPK activation in trained muscle, because in vitro experiments have demonstrated that a progressive decrease in pH induces a progressive increase in AMPK activity (41).

The exercise-induced increase in alpha -AMPK phosphorylation (Thr172) was also lower in the trained than in the sedentary subjects. This indicates that, not only allosteric, but also covalent regulation of AMPK by phosphorylation was different between trained and sedentary subjects. This is in accordance with observations in rat skeletal muscle (13). The regulation of the upstream kinases (AMPKKs) responsible for Thr172 phosphorylation of the alpha -subunit of AMPK is not fully elucidated. However, AMPfree is known to activate AMPKK, leading to phosphorylation and activation of AMPK, but, because of methodological inadequacies, it is unfortunately not feasible to measure AMPfree. In the present study, calculated estimates of AMPfree or AMPfree/ATP could not explain the difference in AMPK phosphorylation. It should be considered that the blunted AMPK activation in trained muscle during acute exercise could be due to enhanced AMPK-directed phosphatase activity in these subjects, although this remains to be shown. The finding that the increase in covalently modified AMPK activity correlated with the decrease in PCr/(PCr + Cr), but not AMPfree or AMPfree/ATP, is not easily explained. However, it should be stressed that the latter were calculated estimates and not direct measures. Probably PCr/(PCr + Cr) is a more accurate measure of cellular energy charge than calculated AMPfree values. PCr has been identified as an allosteric regulator of AMPK, but the ability of PCr to modulate the activity of the upstream AMPKK, or to change the susceptibility of AMPK to phosphorylation-dephosphorylation, has not been found (D. G. Hardie, unpublished observations).

It has been observed that high muscle glycogen levels negatively influence AMPK activity (12, 28, 44, 56). Interestingly, a fairly tight relationship was observed among an exercise-induced increase in alpha 2-AMPK activity, decrease in PCr/(PCr + Cr), and decrease in glycogen content, indicating that glycogen may act in concert with other factors in the modulation of AMPK activity. Taken as a whole, concomitant changes in several factors are likely to contribute to the increased AMPK activity in response to exercise: increased muscle lactate levels leading to acidification, a decrease in PCr/(PCr + Cr), an increase in AMPfree/ATP, and possibly decreased glycogen levels. It could be speculated that the importance of each of these regulator factors varies, depending on the exercise conditions, i.e., exercise duration, exercise intensity, and training status.

AMPK is a promising candidate for mediating several of the adaptive responses in gene expression to exercise training. This is primarily based on the observation that repeated activation of AMPK by AICAR treatment and expression of a constitutively active AMPK mutant in cultured muscle cells mimic many of the changes in protein levels induced by repeated exercise bouts (3, 5, 18, 25, 55). A role for AMPK in regulation of gene transcription is supported by the observations that activation of AMPK regulates expression of several genes in liver cells (16, 30, 31, 58). Furthermore, it has been observed that the transcriptional coactivator p300 is a substrate of AMPK (60) and that AMPK activation by AICAR increases GLUT-4 transcription in muscle (61) with a time course and regional promoter sequence requirement similar to that of exercise (32, 36). Based on the present study, it could be hypothesized that an increase in alpha 1-AMPK protein content is involved in these adaptations, although the role of this AMPK subunit in cellular responses to exercise remains poorly understood. In rat skeletal muscle, exercise training elicited an increase in gamma 3-protein content in red quadriceps, concomitant with an increase in GLUT-4 and other exercise-associated increases in protein levels. Interestingly, there also appeared to be an ~50% increase in the level of alpha 1, although, along with changes in other subunit isoforms, this was not statistically significant. No changes in AMPK subunit protein level in white quadriceps and soleus muscle were observed. However, this could be related to the fact that these muscles were recruited to a low extent, judged from the unchanged GLUT-4 concentration in these two muscles (13). It is not clear at present why the response to training should be different in rats than in humans, although this might reflect the fact that this is a cross-sectional study and that the training regimes are not directly comparable. The finding that chronic alterations in myocardial energetics in hypertrophied rat hearts (left ventricular hypertrophy) are associated with a twofold increase in the alpha 1-protein level and a 30% decrease in the alpha 2-level (51) supports the idea that alpha 1-AMPK protein levels are positively influenced by long-term perturbations of the cellular energy charge, e.g., exercise training. In INS-1 cells, it has been observed that alpha 2 but not alpha 1 is found in the nuclei, suggesting a role of alpha 2 rather than alpha 1 in gene expression (45). It is noteworthy that the alpha 1-protein content was elevated in the trained subjects compared with sedentary subjects, whereas the alpha 1-mRNA level was similar in the trained and sedentary subjects, indicating that the training-induced changes in the alpha 1-AMPK protein content take place at the posttranscriptional level. Alternatively, mRNA levels are increased after each training bout, but the duration of the increase is <1 day, which was the time the trained subjects abstained from training before taking part in the study. Finally, it should be mentioned that, because of the cross-sectional study design, it cannot be excluded that the difference in alpha 1-AMPK protein is due to genetic differences rather than to the effect of training per se. A longitudinal training study would be needed to clarify this. Clearly, more work is needed to address the role of the specific AMPK isoforms in skeletal muscle, but it could be hypothesized that skeletal muscle adaptations to exercise training are dependent in part on changes in the alpha 1-AMPK subunit level. Thus changes in the alpha 1-AMPK subunit level per se might facilitate the beneficial training-induced adaptations in skeletal muscle.

In conclusion, activation of AMPK in response to acute exercise is diminished in skeletal muscle of trained individuals compared with sedentary subjects working at the same relative intensity. This is probably due to a better maintenance of the energy charge and a less pronounced exercise-induced acidification in exercise-trained muscle. Furthermore, AMPK subunit protein level of alpha 1 was higher in exercise-trained than in sedentary human skeletal muscle, suggesting a role for this subunit in the adaptations to exercise training.


    ACKNOWLEDGEMENTS

Ylva Hellsten is acknowledged for measurements of adenosine nucleotides. Christian Frøsig, Betina Bolmgren, Karina Olsen, and Winnie Taagerup are acknowledged for excellent technical contributions.


    FOOTNOTES

This study was supported by a Research and Technological Development Project (QLG1-CT-2001-01488) funded by the European Commission and by Grant 504-14 from the Danish National Research Foundation and the Media and Grants Secretariat of the Danish Ministry of Culture. J. F. P Wojtaszewski was supported by a postdoctoral fellowship from the Danish Medical Research Council. D. G. Hardie was supported by a Programme Grant from the Wellcome Trust (UK) and a Project Grant from Diabetes UK, and K. J. Mustard was supported by a studentship jointly sponsored by the Biotechnology and Biological Sciences Research Council (UK) and Novo-Nordisk.

Address for reprint requests and other correspondence: J. N. Nielsen, Copenhagen Muscle Research Centre, Dept. of Human Physiology, Univ. of Copenhagen, 13 Universitetsparken, DK-2100 Copenhagen, Denmark (E-mail: JNNielsen{at}aki.ku.dk).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

First published October 11, 2002;10.1152/japplphysiol.00642.2002

Received 15 July 2002; accepted in final form 7 October 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Ai, H, Ihlemann J, Hellsten Y, Lauritzen HPMM, Hardie DG, Galbo H, and Ploug T. Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle. Am J Physiol Endocrinol Metab 282: E1291-E1300, 2002[Abstract/Free Full Text].

2.   Baggott, JE, Vaughn WH, and Hudson BB. Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide. Biochem J 236: 193-200, 1986[Web of Science][Medline].

3.   Bergeron, R, Ren JM, Cadman KS, Moore IK, Perret P, Pypaert M, Young LH, Semenkovich CF, and Shulman GI. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 281: E1340-E1346, 2001[Abstract/Free Full Text].

4.   Booth, FW, Chakravarthy MV, Gordon SE, and Spangenburg EE. Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol 93: 3-30, 2002[Abstract/Free Full Text].

5.   Buhl, ES, Jessen N, Schmitz O, Pedersen SB, Pedersen O, Holman GD, and Lund S. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta -D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 50: 12-17, 2001[Abstract/Free Full Text].

6.   Chen, ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, and Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202-E1206, 2000[Abstract/Free Full Text].

7.   Cheung, PC, Salt IP, Davies SP, Hardie DG, and Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 346: 659-669, 2000[Web of Science][Medline].

8.   Chomczynski, P, and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987[Web of Science][Medline].

9.   Davies, SP, Helps NR, Cohen PT, and Hardie DG. 5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett 377: 421-425, 1995[Web of Science][Medline].

10.   Dela, F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN, and Galbo H. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 44: 1010-1020, 1995[Abstract].

11.   Dela, F, Mikines KJ, Von Linstow M, Secher NH, and Galbo H. Effect of training on insulin-mediated glucose uptake in human muscle. Am J Physiol Endocrinol Metab 263: E1134-E1143, 1992.

12.   Derave, W, Ai H, Ihlemann J, Witters LA, Kristiansen S, Richter EA, and Ploug T. Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes 49: 1281-1287, 2000[Abstract].

13.   Durante, PE, Mustard KJ, Park SH, Winder WW, and Hardie DG. Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. Am J Physiol Endocrinol Metab 283: E178-E186, 2002[Abstract/Free Full Text].

14.   Dyck, JR, Gao G, Widmer J, Stapleton D, Fernandez CS, Kemp BE, and Witters LA. Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J Biol Chem 271: 17798-17803, 1996[Abstract/Free Full Text].

15.   Fisher, JS, Gao J, Han DH, Holloszy JO, and Nolte LA. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab 282: E18-E23, 2002[Abstract/Free Full Text].

16.   Foretz, M, Carling D, Guichard C, Ferre P, and Foufelle F. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J Biol Chem 273: 14767-14771, 1998[Abstract/Free Full Text].

17.   Frayn, KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634, 1983[Abstract/Free Full Text].

18.   Fryer, LG, Foufelle F, Barnes K, Baldwin SA, Woods A, and Carling D. Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem J 363: 167-174, 2002[Web of Science][Medline].

19.   Fujii, N, Hayashi T, Hirshman MF, Smith JT, Habinowski SA, Kaijser L, Mu J, Ljungqvist O, Birnbaum MJ, Witters LA, Thorell A, and Goodyear LJ. Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273: 1150-1155, 2000[Web of Science][Medline].

20.   Goodyear, LJ. AMP-activated protein kinase: a critical signaling intermediary for exercise-stimulated glucose transport? Exerc Sport Sci Rev 28: 113-116, 2000[Medline].

21.   Hardie, DG, and Hawley SA. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23: 1112-1119, 2001[Web of Science][Medline].

22.   Hardie, DG, Salt IP, Hawley SA, and Davies SP. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. FEBS Lett 338: 717-722, 1999.

23.   Hawley, SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, and Hardie DG. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271: 27879-27887, 1996[Abstract/Free Full Text].

24.   Hawley, SA, Selbert MA, Goldstein EG, Edelman AM, Carling D, and Hardie DG. 5'-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 270: 27186-27191, 1995[Abstract/Free Full Text].

25.   Holmes, BF, Kurth-Kraczek EJ, and Winder WW. Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 87: 1990-1995, 1999[Abstract/Free Full Text].

26.   Houmard, JA, Tyndall GL, Midyette JB, Hickey MS, Dolan PL, Gavigan KE, Weidner ML, and Dohm GL. Effect of reduced training and training cessation on insulin action and muscle GLUT-4. J Appl Physiol 81: 1162-1168, 1996[Abstract/Free Full Text].

27.   Hutber, CA, Rasmussen BB, and Winder WW. Endurance training attenuates the decrease in skeletal muscle malonyl-CoA with exercise. J Appl Physiol 83: 1917-1922, 1997[Abstract/Free Full Text].

28.   Kawanaka, K, Nolte LA, Han DH, Hansen PA, and Holloszy JO. Mechanisms underlying impaired GLUT-4 translocation in glycogen-supercompensated muscles of exercised rats. Am J Physiol Endocrinol Metab 279: E1311-E1318, 2000[Abstract/Free Full Text].

29.   Lawson, JW, and Veech RL. Effects of pH and free Mg2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. J Biol Chem 254: 6528-6537, 1979[Abstract/Free Full Text].

30.   Leclerc, I, Kahn A, and Doiron B. The 5'-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett 431: 180-184, 1998[Web of Science][Medline].

31.   Lochhead, PA, Salt IP, Walker KS, Hardie DG, and Sutherland C. 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49: 896-903, 2000[Abstract].

32.   MacLean, PS, Zheng D, Jones JP, Olson AL, and Dohm GL. Exercise-induced transcription of the muscle glucose transporter (GLUT 4) gene. Biochem Biophys Res Commun 292: 409-414, 2002[Web of Science][Medline].

33.   Mannion, AF, Jakeman PM, and Willan PL. Determination of human skeletal muscle buffer value by homogenate technique: methods of measurement. J Appl Physiol 75: 1412-1418, 1993[Abstract/Free Full Text].

34.   Markuns, JF, Wojtaszewski JF, and Goodyear LJ. Insulin and exercise decrease glycogen synthase kinase-3 activity by different mechanisms in rat skeletal muscle. J Biol Chem 274: 24896-24900, 1999[Abstract/Free Full Text].

35.   Musi, N, Fujii N, Hirshman MF, Ekberg I, Froberg S, Ljungqvist O, Thorell A, and Goodyear LJ. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 50: 921-927, 2001[Abstract/Free Full Text].

36.   Neufer, PD, and Dohm GL. Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle. Am J Physiol Cell Physiol 265: C1597-C1603, 1993[Abstract/Free Full Text].

37.   Passonneau, JV, and Lowry OH. Enzymatic Analysis---a Practical Guide. Clifton, NJ: Humana, 1993.

38.   Perseghin, G, Price TB, Petersen KF, Roden M, Cline GW, Gerow K, Rothman DL, and Shulman GI. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 335: 1357-1362, 1996[Abstract/Free Full Text].

39.   Phillips, SM, Han XX, Green HJ, and Bonen A. Increments in skeletal muscle GLUT-1 and GLUT-4 after endurance training in humans. Am J Physiol Endocrinol Metab 270: E456-E462, 1996[Abstract/Free Full Text].

40.   Pilegaard, H, Ordway GA, Saltin B, and Neufer PD. Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 279: E806-E814, 2000[Abstract/Free Full Text].

41.   Ponticos, M, Lu QL, Morgan JE, Hardie DG, Partridge TA, and Carling D. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J 17: 1688-1699, 1998[Web of Science][Medline].

42.   Putman, CT, Jones NL, Hultman E, Hollidge-Horvat MG, Bonen A, McConachie DR, and Heigenhauser GJ. Effects of short-term submaximal training in humans on muscle metabolism in exercise. Am J Physiol Endocrinol Metab 275: E132-E139, 1998[Abstract/Free Full Text].

43.   Richter, EA, Derave W, and Wojtaszewski JF. Glucose, exercise and insulin: emerging concepts. J Physiol 535: 313-322, 2001[Abstract/Free Full Text].

44.   Richter, EA, Macdonald C, Kiens B, Hardie DG, and Wojtaszewski JFP Dissociation of 5'AMP-activated protein kinase activity and glucose clearance in human skeletal muscle during exercise (Abstract). Diabetes 50: A62, 2001.

45.   Salt, I, Celler JW, Hawley SA, Prescott A, Woods A, Carling D, and Hardie DG. AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem J 334: 177-187, 1998[Web of Science][Medline].

46.   Shimizu, S, Inoue K, Tani Y, and Yamada H. Enzymatic microdetermination of serum free fatty acids. Anal Biochem 98: 341-345, 1979[Web of Science][Medline].

47.   Stapleton, D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, and Kemp BE. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271: 611-614, 1996[Abstract/Free Full Text].

48.   Stein, SC, Woods A, Jones NA, Davison MD, and Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345: 437-443, 2000[Web of Science][Medline].

49.   Stephens, TJ, Chen ZP, Canny BJ, Michell BJ, Kemp BE, and McConell GK. Progressive increase in human skeletal muscle AMPK-alpha 2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688-E694, 2002[Abstract/Free Full Text].

50.   Thornton, C, Snowden MA, and Carling D. Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle. J Biol Chem 273: 12443-12450, 1998[Abstract/Free Full Text].

51.   Tian, R, Musi N, D'Agostino J, Hirshman MF, and Goodyear LJ. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 104: 1664-1669, 2001[Abstract/Free Full Text].

52.   Tullson, PC, Whitlock DM, and Terjung RL. Adenine nucleotide degradation in slow-twitch red muscle. Am J Physiol Cell Physiol 258: C258-C265, 1990[Abstract/Free Full Text].

53.   Winder, WW. Intramuscular mechanisms regulating fatty acid oxidation during exercise. Adv Exp Med Biol 441: 239-248, 1998[Web of Science][Medline].

54.   Winder, WW. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 91: 1017-1028, 2001[Abstract/Free Full Text].

55.   Winder, WW, Holmes BF, Rubink DS, Jensen EB, Chen M, and Holloszy JO. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88: 2219-2226, 2000[Abstract/Free Full Text].

56.   Wojtaszewski, JF, Jorgensen SB, Hellsten Y, Hardie DG, and Richter EA. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51: 284-292, 2002[Abstract/Free Full Text].

57.   Wojtaszewski, JF, Nielsen P, Hansen BF, Richter EA, and Kiens B. Isoform-specific and exercise intensity-dependent activation of 5'-AMP-activated protein kinase in human skeletal muscle. J Physiol 528: 221-226, 2000[Abstract/Free Full Text].

58.   Woods, A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferre P, Foufelle F, and Carling D. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20: 6704-6711, 2000[Abstract/Free Full Text].

59.   Woods, A, Salt I, Scott J, Hardie DG, and Carling D. The alpha 1 and alpha 2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 397: 347-351, 1996[Web of Science][Medline].

60.   Yang, W, Hong YH, Shen XQ, Frankowski C, Camp HS, and Leff T. Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors. J Biol Chem 276: 38341-38344, 2001[Abstract/Free Full Text].

61.   Zheng, D, MacLean PS, Pohnert SC, Knight JB, Olson AL, Winder WW, and Dohm GL. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J Appl Physiol 91: 1073-1083, 2001[Abstract/Free Full Text].


J APPL PHYSIOL 94(2):631-641
8750-7587/03 $5.00 Copyright © 2003 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Mortensen, P. Poulsen, L. Wegner, K. L. Stender-Petersen, R. Ribel-Madsen, M. Friedrichsen, J. B. Birk, A. Vaag, and J. F. P. Wojtaszewski
Genetic and metabolic effects on skeletal muscle AMPK in young and older twins
Am J Physiol Endocrinol Metab, October 1, 2009; 297(4): E956 - E964.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Ljubicic and D. A. Hood
Specific attenuation of protein kinase phosphorylation in muscle with a high mitochondrial content
Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E749 - E758.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. S. Lee-Young, B. J. Canny, D. E. Myers, and G. K. McConell
AMPK activation is fiber type specific in human skeletal muscle: effects of exercise and short-term exercise training
J Appl Physiol, July 1, 2009; 107(1): 283 - 289.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. Mounier, L. Lantier, J. Leclerc, A. Sotiropoulos, M. Pende, D. Daegelen, K. Sakamoto, M. Foretz, and B. Viollet
Important role for AMPK{alpha}1 in limiting skeletal muscle cell hypertrophy
FASEB J, July 1, 2009; 23(7): 2264 - 2273.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. C. A. Akerstrom, C. P. Fischer, P. Plomgaard, C. Thomsen, G. van Hall, and B. K. Pedersen
Glucose ingestion during endurance training does not alter adaptation
J Appl Physiol, June 1, 2009; 106(6): 1771 - 1779.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. B. Williams, L. N. Sutherland, M. R. Bomhof, S. A. U. Basaraba, A. B. Thrush, D. J. Dyck, C. J. Field, and D. C. Wright
Muscle-specific differences in the response of mitochondrial proteins to {beta}-GPA feeding: an evaluation of potential mechanisms
Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1400 - E1408.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. A. Zwetsloot, L. M. Westerkamp, B. F. Holmes, and T. P. Gavin
AMPK regulates basal skeletal muscle capillarization and VEGF expression, but is not necessary for the angiogenic response to exercise
J. Physiol., December 15, 2008; 586(24): 6021 - 6035.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. B. Wilkinson, S. M. Phillips, P. J. Atherton, R. Patel, K. E. Yarasheski, M. A. Tarnopolsky, and M. J. Rennie
Differential effects of resistance and endurance exercise in the fed state on signalling molecule phosphorylation and protein synthesis in human muscle
J. Physiol., August 1, 2008; 586(15): 3701 - 3717.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. M. Thomson, C. A. Fick, and S. E. Gordon
AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions
J Appl Physiol, March 1, 2008; 104(3): 625 - 632.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. E. Osler and J. R. Zierath
Minireview: Adenosine 5'-Monophosphate-Activated Protein Kinase Regulation of Fatty Acid Oxidation in Skeletal Muscle
Endocrinology, March 1, 2008; 149(3): 935 - 941.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. T. Putman, K. J. B. Martins, M. E. Gallo, G. D. Lopaschuk, J. A. Pearcey, I. M. MacLean, R. J. Saranchuk, and D. Pette
{alpha}-Catalytic subunits of 5'AMP-activated protein kinase display fiber-specific expression and are upregulated by chronic low-frequency stimulation in rat muscle
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1325 - R1334.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. Tosca, C. Chabrolle, S. Uzbekova, and J. Dupont
Effects of Metformin on Bovine Granulosa Cells Steroidogenesis: Possible Involvement of Adenosine 5' Monophosphate-Activated Protein Kinase (AMPK)
Biol Reprod, March 1, 2007; 76(3): 368 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. Freyssenet
Energy sensing and regulation of gene expression in skeletal muscle
J Appl Physiol, February 1, 2007; 102(2): 529 - 540.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. J. Ellingson, D. G. Chesser, and W. W. Winder
Effects of 3-phosphoglycerate and other metabolites on the activation of AMP-activated protein kinase by LKB1-STRAD-MO25
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E400 - E407.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. B. Jorgensen, J. T. Treebak, B. Viollet, P. Schjerling, S. Vaulont, J. F. P. Wojtaszewski, and E. A. Richter
Role of AMPK{alpha}2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E331 - E339.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. B. Birk and J. F. P. Wojtaszewski
Predominant {alpha}2/{beta}2/{gamma}3 AMPK activation during exercise in human skeletal muscle
J. Physiol., December 15, 2006; 577(3): 1021 - 1032.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. De Filippis, K. Cusi, G. Ocampo, R. Berria, S. Buck, A. Consoli, and L. J. Mandarino
Exercise-Induced Improvement in Vasodilatory Function Accompanies Increased Insulin Sensitivity in Obesity and Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4903 - 4910.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Li, D. L. Coven, E. J. Miller, X. Hu, M. E. Young, D. Carling, A. J. Sinusas, and L. H. Young
Activation of AMPK {alpha}- and {gamma}-isoform complexes in the intact ischemic rat heart
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1927 - H1934.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. S. Lee-Young, M. J. Palmer, K. C. Linden, K. LePlastrier, B. J. Canny, M. Hargreaves, G. D. Wadley, B. E. Kemp, and G. K. McConell
Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans
Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E566 - E573.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. M. Crawford, K. J. Treharne, S. Arnaud-Dabernat, J.-Y. Daniel, M. Foretz, B. Viollet, and A. Mehta
Understanding the Molecular Basis of the Interaction between NDPK-A and AMPK {alpha}1
Mol. Cell. Biol., August 1, 2006; 26(15): 5921 - 5931.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. G. Hardie, S. A. Hawley, and J. W. Scott
AMP-activated protein kinase - development of the energy sensor concept
J. Physiol., July 1, 2006; 574(1): 7 - 15.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. Roepstorff, M. Thiele, T. Hillig, H. Pilegaard, E. A. Richter, J. F. P. Wojtaszewski, and B. Kiens
Higher skeletal muscle {alpha}2AMPK activation and lower energy charge and fat oxidation in men than in women during submaximal exercise
J. Physiol., July 1, 2006; 574(1): 125 - 138.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Sriwijitkamol, J. L. Ivy, C. Christ-Roberts, R. A. DeFronzo, L. J. Mandarino, and N. Musi
LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E925 - E932.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Toyoda, S. Tanaka, K. Ebihara, H. Masuzaki, K. Hosoda, K. Sato, T. Fushiki, K. Nakao, and T. Hayashi
Low-intensity contraction activates the {alpha}1-isoform of 5'-AMP-activated protein kinase in rat skeletal muscle
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E583 - E590.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. R. Hancock, E. Janssen, and R. L. Terjung
Contraction-mediated phosphorylation of AMPK is lower in skeletal muscle of adenylate kinase-deficient mice
J Appl Physiol, February 1, 2006; 100(2): 406 - 413.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. K McConell, R. S Lee-Young, Z.-P. Chen, N. K Stepto, N. N Huynh, T. J Stephens, B. J Canny, and B. E Kemp
Short-term exercise training in humans reduces AMPK signalling during prolonged exercise independent of muscle glycogen
J. Physiol., October 15, 2005; 568(2): 665 - 676.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Hurst, E. B. Taylor, T. D. Cline, L. J. Greenwood, C. L. Compton, J. D. Lamb, and W. W. Winder
AMP-activated protein kinase kinase activity and phosphorylation of AMP-activated protein kinase in contracting muscle of sedentary and endurance-trained rats
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E710 - E715.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. F. P Wojtaszewski, J. B Birk, C. Frosig, M. Holten, H. Pilegaard, and F. Dela
5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes
J. Physiol., April 15, 2005; 564(2): 563 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. M. Thomson and S. E. Gordon
Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation
J Appl Physiol, February 1, 2005; 98(2): 557 - 564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. B. Taylor, D. Hurst, L. J. Greenwood, J. D. Lamb, T. D. Cline, S. N. Sudweeks, and W. W. Winder
Endurance training increases LKB1 and MO25 protein but not AMP-activated protein kinase kinase activity in skeletal muscle
Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1082 - E1089.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. A. Clark, Z.-P. Chen, K. T. Murphy, R. J. Aughey, M. J. McKenna, B. E. Kemp, and J. A. Hawley
Intensified exercise training does not alter AMPK signaling in human skeletal muscle
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E737 - E743.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Frosig, S. B. Jorgensen, D. G. Hardie, E. A. Richter, and J. F. P. Wojtaszewski
5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle
Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E411 - E417.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Hojlund, K. J. Mustard, P. Staehr, D. G. Hardie, H. Beck-Nielsen, E. A. Richter, and J. F. P. Wojtaszewski
AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E239 - E244.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Z.-P. Chen, T. J. Stephens, S. Murthy, B. J. Canny, M. Hargreaves, L. A. Witters, B. E. Kemp, and G. K. McConell
Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans
Diabetes, September 1, 2003; 52(9): 2205 - 2212.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. T Putman, M. Kiricsi, J. Pearcey, I. M MacLean, J. A Bamford, G. K Murdoch, W. T Dixon, and D. Pette
AMPK activation increases uncoupling protein-3 expression and mitochondrial enzyme activities in rat muscle without fibre type transitions
J. Physiol., August 15, 2003; 551(1): 169 - 178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. F. P. Wojtaszewski, C. MacDonald, J. N. Nielsen, Y. Hellsten, D. G. Hardie, B. E. Kemp, B. Kiens, and E. A. Richter
Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E813 - E822.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
94/2/631    most recent
00642.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (59)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, J. N.
Right arrow Articles by Wojtaszewski, J. F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, J. N.
Right arrow Articles by Wojtaszewski, J. F. P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online